TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25789661

Group type: EXPERIMENTAL
Intervention: Idarucizumab (doses between 20 mg and 8 g as a 1-hour intravenous infusion, or 1, 2 or 4 g as a 5-minute infusion)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 24314123

Group type: EXPERIMENTAL
Intervention: ELLIPTA DPI
Number of subjects: 75
Study: 21411203

Group type: EXPERIMENTAL
Intervention: Routine screening for CAD
Number of subjects: 1665

Group type: COMPARATOR
Intervention: No screening for CAD
Number of subjects: 1665
Study: 19470877

Group type: EXPERIMENTAL
Intervention: Triple therapy with Aml/Val/HCTZ 10/320/25 mg
Number of subjects: 4285

Group type: COMPARATOR
Intervention: Dual therapies (Val/HCTZ 320/25 mg, Aml/Val 10/320 mg, Aml/HCTZ 10/25 mg)
Number of subjects: 4285
Study: 17407632

Group type: EXPERIMENTAL
Intervention: Intensive multi-injection protocol (two or four times daily regular/NPH insulin injections)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Four times daily insulin injections
Number of subjects: 102

Group type: COMPARATOR
Intervention: Implementation of intensive protocol
Number of subjects: 102
Study: 15379417

Group type: COMPARATOR
Intervention: Adiponectin serum concentrations in obese children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adiponectin serum concentrations in non-obese children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Serum leptin concentrations in obese children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum leptin concentrations in non-obese children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Leptin/adiponectin (L/A) ratio in obese children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leptin/adiponectin (L/A) ratio in non-obese children
Number of subjects: 0
Study: 15204127

Group type: EXPERIMENTAL
Intervention: Multiple-choice task where participants selected possibilities indicating truth or falsity of compound verbal propositions.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cued recall task of verbal propositions.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Old/new recognition paradigm for logical connectives.
Number of subjects: 0
Study: 10407930

Group type: EXPERIMENTAL
Intervention: Preexercise static stretching (4 x 20 s for hamstring muscle group)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonstretched legs (control)
Number of subjects: 10
Study: 7555478

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 2147536

Group type: EXPERIMENTAL
Intervention: Thallium-201 (Tl-201) SPECT
Number of subjects: 24

Group type: COMPARATOR
Intervention: Technetium-99m hexakis 2-methoxyisobutyl isonitrile (Tc-99m MIBI) SPECT
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Stress Tl-201 SPECT
Number of subjects: 24

Group type: COMPARATOR
Intervention: Exercise Tc-99m MIBI SPECT
Number of subjects: 24
Study: 7377911

Group type: EXPERIMENTAL
Intervention: Amitriptyline once daily
Number of subjects: 124

Group type: COMPARATOR
Intervention: Amitriptyline three times daily
Number of subjects: 124
Study: 29190236

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 19
Study: 28985105

Group type: EXPERIMENTAL
Intervention: Jones Jig
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Distal Jet
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (Untreated)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Jones Jig and Distal Jet (Experimental Groups)
Number of subjects: 45
Study: 27621158

Group type: EXPERIMENTAL
Intervention: Advice to take daily probiotics (from October 2013 to March 2014)
Number of subjects: 1302

Group type: COMPARATOR
Intervention: Standard winter advice leaflet (control group)
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Accessing probiotics (among those who did)
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Advice to take daily probiotics
Number of subjects: 1302
Study: 24793365

Group type: EXPERIMENTAL
Intervention: Cannabis dependence
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cannabis dependence (non-abstinent)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy comparison (HC)
Number of subjects: 20
Study: 21926277

Group type: EXPERIMENTAL
Intervention: telephone coaching intervention
Number of subjects: 142

Group type: COMPARATOR
Intervention: control
Number of subjects: 142
Study: 20077490

Group type: EXPERIMENTAL
Intervention: Autofluorescence and diffuse reflectance spectroscopy and spectral imaging
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Separate algorithm for neo‐adjuvant chemotherapy‐treated tissues
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fluorescence and reflectance-based spectral images
Number of subjects: 28
Study: 17690392

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Amodiaquine-sulfalene-pyrimethamine (ASP)
Number of subjects: 181
Study: 15637546

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 1351
Study: 12010236

Group type: EXPERIMENTAL
Intervention: Intracavernosal injection therapy without sexological counselling (‐SC)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Intracavernosal injection therapy with sexological counselling (+SC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (‐SC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (+SC)
Number of subjects: 70
Study: 11011620

Group type: EXPERIMENTAL
Intervention: Viaclin dynamic mattress overlay
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 87
Study: 7787382

Group type: EXPERIMENTAL
Intervention: Generalized epileptiform activity in the EEG (n = 12)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Focal changes in the EEG (n = 18)
Number of subjects: 100
Study: 31736162

Group type: EXPERIMENTAL
Intervention: Nitrate concentrations in boreal lakes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N2 O emissions from lakes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual N2 O emission estimates for Finnish lakes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual N2 O emission estimates for boreal lakes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oversaturation of N2 O in surface water samples
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Global warming potential of N2 O from lakes
Number of subjects: 0
Study: 29683483

Group type: EXPERIMENTAL
Intervention: Elective surgery
Number of subjects: 107

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 107
Study: 26710869

Group type: EXPERIMENTAL
Intervention: High-flux hemodialysis (HFHD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-flux hemodialysis (LFHD)
Number of subjects: 60
Study: 24219770

Group type: EXPERIMENTAL
Intervention: Peer- and health-professional-led self-management education using the Stanford Program
Number of subjects: 43
Study: 21434485

Group type: EXPERIMENTAL
Intervention: Ethanolic extract of Ruta Chalepensis L. (250 microg/ml)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Rutin (1 mM)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Cancer patients (both early and advanced stages)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Cancer patients (advanced stage)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Cancer patients (early stage)
Number of subjects: 56
Study: 18555220

Group type: EXPERIMENTAL
Intervention: Isopropanolic extract of Cimicifuga racemosa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum from treated women
Number of subjects: 0
Study: 16546587

Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 15

Group type: COMPARATOR
Intervention: MAL-PDT
Number of subjects: 15
Study: 15273672

Group type: EXPERIMENTAL
Intervention: Patient education and a physician alerting system (intervention group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual care for the fracture (control group)
Number of subjects: 51
Study: 11203735

Group type: EXPERIMENTAL
Intervention: 0.025% capsaicin cream applied 4 times daily for 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (vehicle cream) applied 4 times daily for 4 weeks
Number of subjects: 30
Study: 9349063

Group type: EXPERIMENTAL
Intervention: Intercuff technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal cuff technique
Number of subjects: 0
Study: 8455153

Group type: EXPERIMENTAL
Intervention: Gold-palladium alloy
Number of subjects: 630

Group type: COMPARATOR
Intervention: Alternative alloys
Number of subjects: 630
Study: 3534850

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 14
Study: 30380365

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (laparoscopy or robot-assisted surgery)
Number of subjects: 631

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery
Number of subjects: 631
Study: 28303520

Group type: EXPERIMENTAL
Intervention: Intra-procedural cortisol assay (IRCA) guiding adrenal vein sampling
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual practice AVS without IRCA
Number of subjects: 200
Study: 25430915

Group type: EXPERIMENTAL
Intervention: Fascia iliaca block (FIB)
Number of subjects: 178

Group type: COMPARATOR
Intervention: 3-in-1 block
Number of subjects: 178
Study: 23254217

Group type: EXPERIMENTAL
Intervention: Coping motives for drinking
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low levels of adaptive coping
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High and low levels of adaptive coping
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Adaptive coping and coping motives interaction
Number of subjects: 50
Study: 21909472

Group type: EXPERIMENTAL
Intervention: β‐calcium pyrophosphate (β‐CPP) plus autograft
Number of subjects: 31

Group type: COMPARATOR
Intervention: Autograft alone
Number of subjects: 31
Study: 18269664

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.1% ointment
Number of subjects: 32

Group type: COMPARATOR
Intervention: Clobetasol 0.05% ointment
Number of subjects: 32
Study: 17172892

Group type: EXPERIMENTAL
Intervention: Fibrin tissue adhesive (Quixil; n = 39)
Number of subjects: 65

Group type: COMPARATOR
Intervention: 8‐0 Vicryl absorbable interrupted sutures (n = 26)
Number of subjects: 65
Study: 12735496

Group type: EXPERIMENTAL
Intervention: Mixed discrete and continuous Cox regression model
Number of subjects: 0
Study: 10795655

Group type: EXPERIMENTAL
Intervention: acrivastine‐pseudoephedrine
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: loratadine‐pseudoephedrine
Number of subjects: 593

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 593
Study: 8624625

Group type: EXPERIMENTAL
Intervention: Piroxicam 20 mg once daily
Number of subjects: 65

Group type: COMPARATOR
Intervention: Tenoxicam 20 mg once daily
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both interventions combined
Number of subjects: 65
Study: 1458892

Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive containing 0.15 mg LNG and 0.03 mg EE2 (Microgynon)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive (Microgynon)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Single dose administration of the same formulation
Number of subjects: 9
Study: 2935811

Group type: EXPERIMENTAL
Intervention: Prednisone-azathioprine-low dose cyclosporin A (8 mg/kg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional regimen (corticosteroid-azathioprine-antilymphocyte globulin)
Number of subjects: 46
Study: 31948327

Group type: EXPERIMENTAL
Intervention: Hand hygiene training program for parents and kindergarteners; duration: 4 weeks; kindergarteners attended 45-minute sessions, parents attended 1-hour sessions.
Number of subjects: 0
Study: 30863254

Group type: EXPERIMENTAL
Intervention: ColActive plus Ag dressing
Number of subjects: 25

Group type: COMPARATOR
Intervention: Traditional dressing (Vaseline and Nitrofurazone)
Number of subjects: 25
Study: 27511027

Group type: EXPERIMENTAL
Intervention: Anteromedial portal (AMP) technique
Number of subjects: 36

Group type: COMPARATOR
Intervention: Transtibial (TT) technique
Number of subjects: 36
Study: 25642640

Group type: EXPERIMENTAL
Intervention: Dancing Group (DG)
Number of subjects: 34
Study: 24016345

Group type: EXPERIMENTAL
Intervention: Femtosecond laser refractive lens surgery
Number of subjects: 20
Study: 22060186

Group type: EXPERIMENTAL
Intervention: Wild blueberry drink
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 0
Study: 18489633

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Overall sleep apnea severity
Number of subjects: 140

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 140
Study: 16949966

Group type: EXPERIMENTAL
Intervention: Middle ear surgery
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (volunteers)
Number of subjects: 33
Study: 15293492

Group type: EXPERIMENTAL
Intervention: ESUS (extended stroke unit service)
Number of subjects: 320

Group type: COMPARATOR
Intervention: OSUS (ordinary stroke unit service)
Number of subjects: 320
Study: 11759643

Group type: EXPERIMENTAL
Intervention: Nephrectomy followed by interferon alfa-2b
Number of subjects: 241

Group type: COMPARATOR
Intervention: Interferon alfa-2b alone
Number of subjects: 241
Study: 9203880

Group type: EXPERIMENTAL
Intervention: Propofol anaesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Inhalational anaesthesia
Number of subjects: 40
Study: 7949091

Group type: EXPERIMENTAL
Intervention: Low levels of factor VII (FVII) in homozygous FVII-deficient patients
Number of subjects: 33
Study: 3422792

Group type: EXPERIMENTAL
Intervention: Bupivacaine plus diflunisal (500 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Lidocaine plus diflunisal (500 mg)
Number of subjects: 26
Study: 31626067

Group type: EXPERIMENTAL
Intervention: Take a Stand! intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 28646527

Group type: EXPERIMENTAL
Intervention: Dentalvibe® (DV) - buccal and palatal infiltration on the maxilla and inferior alveolar nerve block (IANB) with vibration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional method (TR) - same injections without vibration
Number of subjects: 40
Study: 27349592

Group type: EXPERIMENTAL
Intervention: Fibrin sealant
Number of subjects: 20

Group type: COMPARATOR
Intervention: Suture (buried 6-0 Vicryl)
Number of subjects: 20
Study: 24836354

Group type: EXPERIMENTAL
Intervention: Mixed-meal tolerance test
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: C-peptide measurement using chemiluminescent immunoassay
Number of subjects: 58
Study: 22210578

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 443

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 443
Study: 20350952

Group type: EXPERIMENTAL
Intervention: ASA 500 mg/PSE 30 mg
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: ASA 1000 mg/PSE 60 mg
Number of subjects: 640

Group type: COMPARATOR
Intervention: APAP 1000 mg/PSE 60 mg
Number of subjects: 640
Study: 18245404

Group type: EXPERIMENTAL
Intervention: Atomoxetine (1.2 mg/kg per day)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study: 15007599

Group type: EXPERIMENTAL
Intervention: Scanner-assisted CO2 laser microincision
Number of subjects: 155

Group type: COMPARATOR
Intervention: Manually guided CO2 laser microincision (Acuspot micromanipulator)
Number of subjects: 155
Study: 14608246

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 10754373

Group type: EXPERIMENTAL
Intervention: H. pylori positive
Number of subjects: 66

Group type: COMPARATOR
Intervention: H. pylori negative
Number of subjects: 66
Study: 8926225

Group type: EXPERIMENTAL
Intervention: Enforcement schedules of 2 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enforcement schedules of 4 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enforcement schedules of 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no enforcement)
Number of subjects: 0
Study: 1949926

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intramuscular (IM) dosing
Number of subjects: 6
Study: 6547808

Group type: COMPARATOR
Intervention: Cookies with 20 g of Fusarium graminearium
Number of subjects: 150

Group type: COMPARATOR
Intervention: Cupcakes with 10 g of Paecilomyces variotii
Number of subjects: 150

Group type: COMPARATOR
Intervention: Milk (control for nutritive value studies)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fusarium graminearium (nutritive value)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Paecilomyces variotii (nutritive value)
Number of subjects: 150
Study: 31732062

Group type: EXPERIMENTAL
Intervention: Yacon syrup (40g, 14g of FOS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (40g)
Number of subjects: 40
Study: 29653651

Group type: EXPERIMENTAL
Intervention: 7F sheathless guide catheter
Number of subjects: 41

Group type: COMPARATOR
Intervention: 6F sheath/guide combination
Number of subjects: 41
Study: 26678873

Group type: EXPERIMENTAL
Intervention: C15:0
Number of subjects: 1180

Group type: EXPERIMENTAL
Intervention: C17:0
Number of subjects: 1180
Study: 1427246

Group type: EXPERIMENTAL
Intervention: Exercise and cognitive-behavioral programs
Number of subjects: 230

Group type: COMPARATOR
Intervention: Discussion control program
Number of subjects: 230
Study: 22814748

Group type: EXPERIMENTAL
Intervention: GW501516 10 mg
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: GW501516 5 mg and 10 mg (exploratory study)
Number of subjects: 268
Study: 20642768

Group type: EXPERIMENTAL
Intervention: alpha-bisabolol-containing cream applied once a day for 8 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: vehicle control cream
Number of subjects: 28
Study: 19216199

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15791171

Group type: EXPERIMENTAL
Intervention: Methohexital alone (80-100 mg IV bolus)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Remifentanil (500 mcg IV bolus) with low-dose methohexital (40 mg IV)
Number of subjects: 110
Study: 12460132

Group type: EXPERIMENTAL
Intervention: Self-reported cannabis use
Number of subjects: 248

Group type: COMPARATOR
Intervention: On-site qualitative urine screening
Number of subjects: 248

Group type: COMPARATOR
Intervention: Laboratory testing
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Kappa coefficients
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Positive urine tests
Number of subjects: 248
Study: 10505742

Group type: EXPERIMENTAL
Intervention: sIL‐2R
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sTNFR
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: IL‐1beta
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: IL‐2
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: IL‐8
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: TNF‐alpha
Number of subjects: 35
Study: 9198431

Group type: EXPERIMENTAL
Intervention: IAN block + IO injection (2% lidocaine with 1:100,000 epinephrine)
Number of subjects: 40

Group type: COMPARATOR
Intervention: IAN block (mock IO injection)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IO injection
Number of subjects: 40
Study: 1761896

Group type: EXPERIMENTAL
Intervention: Rokitamycin (RKM) 600 mg daily for 5 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ofloxacin (OFLX) 600 mg daily for 5 days
Number of subjects: 90
Study: 3880670

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 35
Study: 30803141

Group type: EXPERIMENTAL
Intervention: Intra-oral camera (IOC)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Text messages (TM)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Intra-oral camera (IOC) + Text messages (TM)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 142
Study: 29950229

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone + bortezomib + thalidomide (Group A)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone + bortezomib + thalidomide (Group B)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo + bortezomib + thalidomide (Group C)
Number of subjects: 96
Study: 26558356

Group type: EXPERIMENTAL
Intervention: IV‐PCA with propacetamol (4 g)
Number of subjects: 108

Group type: COMPARATOR
Intervention: IV‐PCA with normal saline mixed to fentanyl (20 μg/kg)
Number of subjects: 108
Study: 25301463

Group type: EXPERIMENTAL
Intervention: Intravenous serelaxin for 48 hours
Number of subjects: 1161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1161
Study: 22707187

Group type: EXPERIMENTAL
Intervention: Zofenopril (60 mg/day) plus ASA (100 mg/day)
Number of subjects: 771

Group type: COMPARATOR
Intervention: Ramipril (10 mg/day) plus ASA (100 mg/day)
Number of subjects: 771
Study: 20540652

Group type: EXPERIMENTAL
Intervention: pioglitazone (15-30 mg/day) plus conventional oral hypoglycemic agents
Number of subjects: 63

Group type: COMPARATOR
Intervention: conventional oral hypoglycemic agents alone
Number of subjects: 63
Study: 21385259

Group type: EXPERIMENTAL
Intervention: Information sessions for recruitment
Number of subjects: 269

Group type: COMPARATOR
Intervention: Women with legal guardians
Number of subjects: 269

Group type: COMPARATOR
Intervention: Women without legal guardians
Number of subjects: 269
Study: 16048218

Group type: EXPERIMENTAL
Intervention: TenderWet 24
Number of subjects: 42

Group type: COMPARATOR
Intervention: Iruxol N (Santyl)
Number of subjects: 42
Study: 12450902

Group type: EXPERIMENTAL
Intervention: Calcium-fortified orange juice
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplement
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Skim milk
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-calcium diet (1300 mg/d)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-calcium diet (300 mg/d)
Number of subjects: 12